Your browser doesn't support javascript.
loading
Improved biopharmaceutical performance of antipsychotic drug using lipid nanoparticles via intraperitoneal route.
Ouyang, Hezhong; Hu, Jinquan; Qiu, XingYing; Wu, Shaochang; Guo, Fudong; Tan, Youguo.
Affiliation
  • Ouyang H; Department of Neurology, The People's Hospital of Danyang, Danyang, China.
  • Hu J; Department of Neurology, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
  • Qiu X; Department of Neurology, People's Liberation Army Joint Support Force 900th Hospital, Cangshan Hospital District, Fuzhou, China.
  • Wu S; Department of Geriatrics, The Second People's Hospital of LiShui, Lishui, China.
  • Guo F; Department of Neurology, Affiliated Hospital of Chifeng University, Chifeng city, China.
  • Tan Y; Department of Psychiatry, Zigong Mental health Centre, Zigong, China.
Pharm Dev Technol ; 27(7): 853-863, 2022 Sep.
Article in En | MEDLINE | ID: mdl-36124550

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antipsychotic Agents / Biological Products / Nanoparticles Type of study: Prognostic_studies Limits: Animals Language: En Journal: Pharm Dev Technol Journal subject: FARMACIA Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antipsychotic Agents / Biological Products / Nanoparticles Type of study: Prognostic_studies Limits: Animals Language: En Journal: Pharm Dev Technol Journal subject: FARMACIA Year: 2022 Document type: Article Affiliation country: Country of publication: